GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sandoz Group AG (OTCPK:SDZNY) » Definitions » Pretax Margin %

Sandoz Group AG (Sandoz Group AG) Pretax Margin % : 1.30% (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Sandoz Group AG Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Sandoz Group AG's Pre-Tax Income for the three months ended in Dec. 2023 was $130 Mil. Sandoz Group AG's Revenue for the three months ended in Dec. 2023 was $9,979 Mil. Therefore, Sandoz Group AG's pretax margin for the quarter that ended in Dec. 2023 was 1.30%.

The historical rank and industry rank for Sandoz Group AG's Pretax Margin % or its related term are showing as below:

SDZNY' s Pretax Margin % Range Over the Past 10 Years
Min: 1.3   Med: 6.57   Max: 11.84
Current: 1.3


SDZNY's Pretax Margin % is ranked worse than
57.88% of 1021 companies
in the Drug Manufacturers industry
Industry Median: 4.12 vs SDZNY: 1.30

Sandoz Group AG Pretax Margin % Historical Data

The historical data trend for Sandoz Group AG's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sandoz Group AG Pretax Margin % Chart

Sandoz Group AG Annual Data
Trend Dec22 Dec23
Pretax Margin %
11.84 1.30

Sandoz Group AG Quarterly Data
Dec22 Dec23
Pretax Margin % 11.84 1.30

Competitive Comparison of Sandoz Group AG's Pretax Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Sandoz Group AG's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sandoz Group AG's Pretax Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sandoz Group AG's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Sandoz Group AG's Pretax Margin % falls into.



Sandoz Group AG Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Sandoz Group AG's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=130/9979
=1.30 %

Sandoz Group AG's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=130/9979
=1.30 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sandoz Group AG  (OTCPK:SDZNY) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Sandoz Group AG Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Sandoz Group AG's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Sandoz Group AG (Sandoz Group AG) Business Description

Traded in Other Exchanges
Address
Forum 1, Novartis Campus, Basel, CHE, CH-4056
Sandoz is one of the largest generic pharmaceutical manufacturers in the world, generating over $9 billion annually from off-patent drugs. Once part of Novartis, Sandoz spun off and went public in October 2023. Generics, including small molecules and complex injectables, make up roughly 75% of Sandoz's total sales, and the firm has a significant presence in Europe, the United States, and other key international markets. Sandoz generates its remaining sales from biosimilars and is among leaders in the space. Sandoz launched Europe's first biosimilar, Omnitrope, in 2006 as well as U.S.'s first biosimilar, Zarxio, in 2015. It currently has eight commercialized biosimilars in a number of markets and has over 20 assets in pipeline.

Sandoz Group AG (Sandoz Group AG) Headlines

From GuruFocus

Q3 2023 Sandoz Group AG Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q3 2023 Sandoz Group AG Earnings Call Transcript

By GuruFocus Research 02-14-2024